FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1917994758> ?p ?o ?g. }

• W1917994758 endingPage "E9" @default.
• W1917994758 startingPage "E1" @default.
• W1917994758 abstract "This phase II, multicenter, randomized, double-blind, non-comparative study assessed the efficacy and safety of immediate-release octreotide and octreotide LAR, in combination with corticosteroids and standard medical care, on the symptoms of inoperable malignant bowel obstruction (MBO) due to peritoneal carcinomatosis. The primary efficacy endpoint was success at day 14 defined as a composite endpoint including the absence of a nasogastric tube, and vomiting less than twice per day and no use of anticholinergic agents. Patients in the octreotide arm received octreotide LAR 30 mg intramuscular (im) on days 1, 29 and 57, as well as daily immediate-release octreotide 600 μg per day plus methylprednisolone on days 1 to 6. Placebo-treated patients received methylprednisolone and matched placebo instead of octreotide. Difficulties associated with enrolling patients at palliative-care stage meant only 64 patients (instead of the planned 102 patients) were randomized, 32 to octreotide and 32 to placebo. Despite randomization, more patients in the octreotide arm (46.4%) than in the placebo arm (21.9%) had a baseline Karnofsky score less than 50. An intention-to-treat analysis showed that in the octreotide and placebo arms, 12 (38%) and nine (28%), respectively, patients were successfully treated at day 14, which increased to 9/15 (60%) and 7/25 (28%), respectively, among patients with a baseline Karnofsky score greater or equal to 50. Octreotide-treated patients reported three drug-related adverse events (AEs), and no drug-related serious AEs or deaths. Octreotide LAR may have a key role in treating patients with a MBO due to peritoneal carcinomatosis, particularly in those with moderately severe disease." @default.
• W1917994758 created "2016-06-24" @default.
• W1917994758 creator A5000284560 @default.
• W1917994758 creator A5003576303 @default.
• W1917994758 creator A5008260494 @default.
• W1917994758 creator A5025316362 @default.
• W1917994758 creator A5026243055 @default.
• W1917994758 creator A5032836718 @default.
• W1917994758 creator A5052299853 @default.
• W1917994758 creator A5067174265 @default.
• W1917994758 creator A5076309223 @default.
• W1917994758 creator A5084467861 @default.
• W1917994758 creator A5087048554 @default.
• W1917994758 date "2012-02-01" @default.
• W1917994758 modified "2023-09-26" @default.
• W1917994758 title "SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction" @default.
• W1917994758 cites W1524833588 @default.
• W1917994758 cites W1987149638 @default.
• W1917994758 cites W2006962214 @default.
• W1917994758 cites W2022496198 @default.
• W1917994758 cites W2026229634 @default.
• W1917994758 cites W2029409133 @default.
• W1917994758 cites W2034903741 @default.
• W1917994758 cites W2045734354 @default.
• W1917994758 cites W2049838395 @default.
• W1917994758 cites W2054521520 @default.
• W1917994758 cites W2060306701 @default.
• W1917994758 cites W2102625590 @default.
• W1917994758 cites W2108543265 @default.
• W1917994758 cites W2167064059 @default.
• W1917994758 cites W2591310694 @default.
• W1917994758 cites W2616463740 @default.
• W1917994758 cites W4249494403 @default.
• W1917994758 doi "https://doi.org/10.1684/bdc.2011.1535" @default.
• W1917994758 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22265994" @default.
• W1917994758 hasPublicationYear "2012" @default.
• W1917994758 type Work @default.
• W1917994758 sameAs 1917994758 @default.
• W1917994758 citedByCount "39" @default.
• W1917994758 countsByYear W19179947582012 @default.
• W1917994758 countsByYear W19179947582013 @default.
• W1917994758 countsByYear W19179947582014 @default.
• W1917994758 countsByYear W19179947582015 @default.
• W1917994758 countsByYear W19179947582016 @default.
• W1917994758 countsByYear W19179947582017 @default.
• W1917994758 countsByYear W19179947582018 @default.
• W1917994758 countsByYear W19179947582019 @default.
• W1917994758 countsByYear W19179947582020 @default.
• W1917994758 countsByYear W19179947582021 @default.
• W1917994758 countsByYear W19179947582022 @default.
• W1917994758 countsByYear W19179947582023 @default.
• W1917994758 crossrefType "journal-article" @default.
• W1917994758 hasAuthorship W1917994758A5000284560 @default.
• W1917994758 hasAuthorship W1917994758A5003576303 @default.
• W1917994758 hasAuthorship W1917994758A5008260494 @default.
• W1917994758 hasAuthorship W1917994758A5025316362 @default.
• W1917994758 hasAuthorship W1917994758A5026243055 @default.
• W1917994758 hasAuthorship W1917994758A5032836718 @default.
• W1917994758 hasAuthorship W1917994758A5052299853 @default.
• W1917994758 hasAuthorship W1917994758A5067174265 @default.
• W1917994758 hasAuthorship W1917994758A5076309223 @default.
• W1917994758 hasAuthorship W1917994758A5084467861 @default.
• W1917994758 hasAuthorship W1917994758A5087048554 @default.
• W1917994758 hasConcept C126322002 @default.
• W1917994758 hasConcept C141071460 @default.
• W1917994758 hasConcept C142724271 @default.
• W1917994758 hasConcept C168563851 @default.
• W1917994758 hasConcept C197934379 @default.
• W1917994758 hasConcept C203092338 @default.
• W1917994758 hasConcept C204243189 @default.
• W1917994758 hasConcept C204787440 @default.
• W1917994758 hasConcept C27081682 @default.
• W1917994758 hasConcept C2776297358 @default.
• W1917994758 hasConcept C2781025020 @default.
• W1917994758 hasConcept C71924100 @default.
• W1917994758 hasConceptScore W1917994758C126322002 @default.
• W1917994758 hasConceptScore W1917994758C141071460 @default.
• W1917994758 hasConceptScore W1917994758C142724271 @default.
• W1917994758 hasConceptScore W1917994758C168563851 @default.
• W1917994758 hasConceptScore W1917994758C197934379 @default.
• W1917994758 hasConceptScore W1917994758C203092338 @default.
• W1917994758 hasConceptScore W1917994758C204243189 @default.
• W1917994758 hasConceptScore W1917994758C204787440 @default.
• W1917994758 hasConceptScore W1917994758C27081682 @default.
• W1917994758 hasConceptScore W1917994758C2776297358 @default.
• W1917994758 hasConceptScore W1917994758C2781025020 @default.
• W1917994758 hasConceptScore W1917994758C71924100 @default.
• W1917994758 hasIssue "2" @default.
• W1917994758 hasLocation W19179947581 @default.
• W1917994758 hasLocation W19179947582 @default.
• W1917994758 hasOpenAccess W1917994758 @default.
• W1917994758 hasPrimaryLocation W19179947581 @default.
• W1917994758 hasRelatedWork W1994531211 @default.
• W1917994758 hasRelatedWork W2003090610 @default.
• W1917994758 hasRelatedWork W2039865683 @default.
• W1917994758 hasRelatedWork W2158273200 @default.
• W1917994758 hasRelatedWork W2559946394 @default.
• W1917994758 hasRelatedWork W2766008196 @default.

• next